| Product NDC: | 54859-702 |
| Proprietary Name: | Conex |
| Non Proprietary Name: | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
| Active Ingredient(s): | 2; 60 mg/1; mg/1 & nbsp; Dexbrompheniramine Maleate, Pseudoephedrine HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54859-702 |
| Labeler Name: | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20071101 |
| Package NDC: | 54859-702-60 |
| Package Description: | 60 TABLET in 1 BOTTLE (54859-702-60) |
| NDC Code | 54859-702-60 |
| Proprietary Name | Conex |
| Package Description | 60 TABLET in 1 BOTTLE (54859-702-60) |
| Product NDC | 54859-702 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071101 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
| Substance Name | DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 2; 60 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |